References
- BanghamADStandishMMWatkinsalJCDiffusion of univalent ions across the lamellae of swollen phospholipidsJ Mol Biol19651312382525859039
- LaVanDAMcGuireTLangerRSmall-scale systems for in vivo drug deliveryNat Biotechnol200321101184119114520404
- LangerRNew methods of drug deliveryScience19902494976152715332218494
- ShiJJXiaoZKamalyNFarokhzadOCSelf-assembled targeted nanoparticles: evolution of technologies and bench to bedside translationAcc Chem Res201144101123113421692448
- YangYYuCAdvances in silica based nanoparticles for targeted cancer therapyNanomedicine201612231733226706409
- SchleichNPoCJacobsDComparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapyJ Control Release2014194829125178270
- MitraSGaurUGhoshPCMaitraANTumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrierJ Control Release2001741–331732311489513
- SteichenSDCaldorera-MooreMPeppasNAA review of current nanoparticle and targeting moieties for the delivery of cancer therapeuticsEur J Pharm Sci201348341642723262059
- WangXLiSShiYThe development of site-specific drug delivery nanocarriers based on receptor mediationJ Control Release201419313915324862317
- ThomsenLBThomsenMSMoosTTargeted drug delivery to the brain using magnetic nanoparticlesTher Deliv20156101145115526446407
- XiongLBiJTangYQiaoSZMagnetic core-shell silica nanoparticles with large radial mesopores for siRNA deliverySmall201612344735474227199216
- DavisMEZuckermanJEChoiCHEvidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature201046472911067107020305636
- VarshosazJFarzanMNanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinomaWorld J Gastroenterol20152142120221204126576089
- BarretoJAO’ MalleyWKubeilMGrahamBStephanHSpicciaLNanomaterials: applications in cancer imaging and therapyAdv Mater20112312H18H4021433100
- ArgyoCWeissVBräuchleCBeinTMultifunctional mesoporous silica nanoparticles as a universal platform for drug deliveryChem Mater2014261435451
- Vivero-EscotoJLSlowingIITrewynBGLinVSMesoporous silica nanoparticles for intracellular controlled drug deliverySmall20106181952196720690133
- ReaIMartucciNMDe StefanoLDiatomite biosilica nanocarriers for siRNA transport inside cancer cellsBiochim Biophys Acta20141840123393340325224732
- RuggieroITerraccianoMMartucciNMDiatomite silica nanoparticles for drug deliveryNanoscale Res Lett20149132933525024689
- TerraccianoMShahbaziMACorreiaASurface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug deliveryNanoscale2015747200632007426568517
- ZhangHShahbaziMAMäkiläEMDiatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamineBiomaterials201334369210921924008036
- MigkouMDimopoulosMAGavriatopoulouMTerposEApplications of monoclonal antibodies for the treatment of hematological malignanciesExpert Opin Biol Ther20099220722019236251
- ReedJCBcl-2-family proteins and hematologic malignancies: history and future prospectsBlood200811173322333018362212
- Chanan-KhanABcl-2 antisense therapy in B-cell malignanciesBlood Rev200519421322115784299
- AbdullahLNChowEK-HMechanisms of chemoresistance in cancer stem cellsClin Transl Med20132131123369605
- BanerjeeAQianPWuZ-SArtemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell like behavior in mammary carcinoma cellsJ Biol Chem201228751425024251523095743
- EbrahimASSabbaghHLiddaneARaufiAKandouzMAl-KatibAHematologic malignancies: newer strategies to counter the BCL-2 proteinJ Cancer Res Clin Oncol201614292013202227043233
- O’ BrienSMooreJOBoydTERandomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemiaJ Clin Oncol20072591114112017296974
- CotterFEWatersJCunninghamDHuman Bcl-2 antisense therapy for lymphomasBiochim Biophys Acta1999148919710610807000
- PalmieriCFalconeCIaccinoEIn vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binderBlood2010116222623820363775
- MigliaccioNPalmieriCRuggieroIB-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapyCancer Cell Int201515505825983658
- WangYHuangHYYangLZhangZJiHCetuximab-modified mesoporous silica nano-medicine specifically targets EGFR-mutant lung cancer and overcomes drug resistanceSci Rep20166254682547727151505
- De StefanoLOlivieroGAmatoJAminosilane functionalizations of mesoporous oxidized silicon for oligonucleotide synthesis and detectionJ R Soc Interface201310832013016023536541
- TerraccianoMReaIPolitiJDe StefanoLOptical characterization of aminosilane-modified silicon dioxide surface for biosensingJ Eur Opt Soc Rapid Publ201381303
- KimKJKanellopoulos-LangevinCMerwinRMSachsDHAsofskyREstablishment and characterization of BALB/c lymphoma lines with B cell propertiesJ Immunol19791222549554310843
- SpatuzzaCSchiavoneMDi SalleEPhysical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton’s tyrosine kinase: evidence for three protein isoforms of IBtkNucleic Acids Res200836134402441618596081
- BradfordMMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem1976721248254942051
- SanOGörenRÖzgürCPurification of diatomite powder by acid leaching for use in fabrication of porous ceramicsInt J Mine Process2009931610
- MartucciNMReaIRuggieroIA new strategy for label-free detection of lymphoma cancer cellsBiomed Opt Express2015641353136225909019
- De AngelisFPujiaAFalconeCWater soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor contextNanoscale20102102230223620835434
- LoikeJDSilversteinSCA fluorescence quenching technique using trypan blue to differentiate between attached and ingested glutaraldehyde-fixed red blood cells in phagocytosing murine macrophagesJ Immunol Methods1983571–33733796402550
- KouLSunJZhaiYHeZThe endocytosis and intracellular fate of nanomedicines: implication for rational designAsian J Pharmaceut Sci201381110
- BannunahAMVllasaliuDLordJStolnikSMechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface chargeMol Pharm201411124363437325327847
- VecchioneRLucianiGCalcagnoVMultilayered silicabiopolymer nanocapsules with a hydrophobic core and a hydrophilic tunable shell thicknessNanoscale20168168798880927065306
- LoveSAMaurer-JonesMAThompsonJWLinYHaynesCLAssessing nanoparticle toxicityAnnu Rev Anal Chem20125181205
- RosenholmJMMeinanderAPeuhuETargeting of porous hybrid silica nanoparticles to cancer cellsACS Nano20093119720619206267
- LuJLiongMLiZZinkJITamanoiFBiocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animalsSmall20106161794180520623530
- VarnaMRatajczakPFerreiraILeboeufCBousquetGJaninAIn vivo distribution of inorganic nanoparticles in preclinical modelsJ Biomater Nanobiotechnol201232A269279
- ScarfòLGhiaPReprogramming cell death: BCL2 family inhibition in hematological malignanciesImmunol Lett20131551–2363924095849
- Garcıa-SaezAJThe secrets of the Bcl-2 familyCell Death Differ2012191733174022935609
- DingLHuXMWuHCombined transfection of Bcl-2 siRNA and miR-15a oligonucleotides enhanced methotrexate-induced apoptosis in Raji cellsCancer Biol Med2013101162123691440
- HatakeyamaHItoEAkitaHA pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivoJ Control Release2009139212713219540888
- MinakuchiYTakeshitaFKosakaNAtelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivoNucleic Acids Res20043213e10915272050
- HeDFangBSmall hairpin RNA targeting at Bcl-2 increases cytarabine induced apoptosis in Raji cellsActa Biochim Biophys Sin (Shanghai)200941213113619204830
- NagamatsuKTsuchiyaFOgumaKMaruyamaHKanoRHasegawaAThe effect of small interfering RNA (siRNA) against the Bcl-2 gene on apoptosis and chemosensitivity in a canine mammary gland tumor cell lineRes Vet Sci2008841495517537469